These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12921927)

  • 41. The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: a study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD.
    Pacyna JE; Kim S; Yost K; Sedlacek H; Petereit D; Kaur J; Rapkin B; Grubb R; Paskett E; Chang GJ; Sloan J; Basch E; Major B; Novotny P; Taylor J; Buckner J; Parsons JK; Morris M; Tilburt JC
    BMC Cancer; 2018 Aug; 18(1):788. PubMed ID: 30081846
    [TBL] [Abstract][Full Text] [Related]  

  • 42. To explore the experience of research nurses who obtain consent from adults in emergency settings to participate in clinical trials, either prospectively or post enrolment.
    Brown P; Newham R; Hewison A
    J Clin Nurs; 2020 Aug; 29(15-16):3054-3063. PubMed ID: 32441860
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomized, embedded trial of pre-notification of trial participation did not increase recruitment rates to a falls prevention trial.
    Arundel C; Jefferson L; Bailey M; Cockayne S; Hicks K; Loughrey L; Rodgers S; Torgerson DJ;
    J Eval Clin Pract; 2017 Feb; 23(1):73-78. PubMed ID: 27320133
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Peer Review Intervention for Monitoring and Evaluating sites (PRIME) that improved randomized controlled trial conduct and performance.
    Lane JA; Wade J; Down L; Bonnington S; Holding PN; Lennon T; Jones AJ; Salter CE; Neal DE; Hamdy FC; Donovan JL;
    J Clin Epidemiol; 2011 Jun; 64(6):628-36. PubMed ID: 21239142
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
    Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A cost-effectiveness analysis of subject recruitment strategies in the HIPAA era: results from a colorectal cancer screening adherence trial.
    Schroy PC; Glick JT; Robinson P; Lydotes MA; Heeren TC; Prout M; Davidson P; Wong JB
    Clin Trials; 2009 Dec; 6(6):597-609. PubMed ID: 19933718
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recruitment for a hospital-based pragmatic clinical trial using volunteer nurses and students.
    Blewer AL; Li J; Ikeda DJ; Leary M; Buckler DG; Riegel B; Desai S; Groeneveld PW; Putt ME; Abella BS
    Clin Trials; 2016 Aug; 13(4):425-33. PubMed ID: 27094486
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Laparoscopic supracervical hysterectomy compared with second-generation endometrial ablation for heavy menstrual bleeding: the HEALTH RCT.
    Cooper K; Breeman S; Scott NW; Scotland G; Hernández R; Clark TJ; Hawe J; Hawthorn R; Phillips K; Wileman S; McCormack K; Norrie J; Bhattacharya S
    Health Technol Assess; 2019 Sep; 23(53):1-108. PubMed ID: 31577219
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost effectiveness of recruitment methods in an obesity prevention trial for young children.
    Robinson JL; Fuerch JH; Winiewicz DD; Salvy SJ; Roemmich JN; Epstein LH
    Prev Med; 2007 Jun; 44(6):499-503. PubMed ID: 17475318
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study.
    Brown LC; Ahmed HU; Faria R; El-Shater Bosaily A; Gabe R; Kaplan RS; Parmar M; Collaco-Moraes Y; Ward K; Hindley RG; Freeman A; Kirkham A; Oldroyd R; Parker C; Bott S; Burns-Cox N; Dudderidge T; Ghei M; Henderson A; Persad R; Rosario DJ; Shergill I; Winkler M; Soares M; Spackman E; Sculpher M; Emberton M
    Health Technol Assess; 2018 Jul; 22(39):1-176. PubMed ID: 30040065
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recruitment of trial participants through electronic medical record patient portal messaging: A pilot study.
    Plante TB; Gleason KT; Miller HN; Charleston J; McArthur K; Himmelfarb CD; Lazo M; Ford DE; Miller ER; Appel LJ; Juraschek SP;
    Clin Trials; 2020 Feb; 17(1):30-38. PubMed ID: 31581836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.
    Lane A; Metcalfe C; Young GJ; Peters TJ; Blazeby J; Avery KN; Dedman D; Down L; Mason MD; Neal DE; Hamdy FC; Donovan JL;
    BJU Int; 2016 Dec; 118(6):869-879. PubMed ID: 27415448
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.
    Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
    Lancet Oncol; 2019 Feb; 20(2):267-281. PubMed ID: 30579763
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intensity-modulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation.
    Hummel S; Simpson EL; Hemingway P; Stevenson MD; Rees A
    Health Technol Assess; 2010 Oct; 14(47):1-108, iii-iv. PubMed ID: 21029717
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Qualitative research in evidence-based medicine: improving decision-making and participation in randomized controlled trials of cancer treatments.
    Audrey S
    Palliat Med; 2011 Dec; 25(8):758-65. PubMed ID: 21844137
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Validation of the Hospital Episode Statistics Outpatient Dataset in England.
    Thorn JC; Turner E; Hounsome L; Walsh E; Donovan JL; Verne J; Neal DE; Hamdy FC; Martin RM; Noble SM
    Pharmacoeconomics; 2016 Feb; 34(2):161-8. PubMed ID: 26386702
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Managing localized prostate cancer by radical prostatectomy or watchful waiting: Cost analysis of a randomized trial (SPCG-4).
    Andersson SO; Andrén O; Lyth J; Stark JR; Henriksson M; Adami HO; Carlsson P; Johansson JE
    Scand J Urol Nephrol; 2011 Apr; 45(3):177-83. PubMed ID: 21265595
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical and cost-effectiveness of new and emerging technologies for early localised prostate cancer: a systematic review.
    Hummel S; Paisley S; Morgan A; Currie E; Brewer N
    Health Technol Assess; 2003; 7(33):iii, ix-x, 1-157. PubMed ID: 14609482
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recruiting older men for geriatric suicide research.
    Bhar SS; Wiltsey-Stirman S; Zembroski D; McCray L; Oslin DW; Brown GK; Beck AT
    Int Psychogeriatr; 2013 Jan; 25(1):88-95. PubMed ID: 22929086
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.